Richeng Mao

机构：Fudan University, Huashan Hospital · ORCID：0000-0001-5534-8299

发表论文 106 篇 · 总被引 3038 次 · h-index 27

代表论文

• BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4+ T-cell exhaustion (2024 · Nature Communications · 被引 43)
• A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease (2024 · Hepatology International · 被引 33)
• PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trial (2024 · Journal of Hepatology · 被引 23)
• Incidence and severity of SARS‐CoV‐2 reinfection, a multicenter cohort study in Shanghai, China (2023 · Journal of Medical Virology · 被引 20)
• Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies (2023 · Cell Discovery · 被引 18)
• End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation (2023 · Frontiers in Cellular and Infection Microbiology · 被引 12)